EATRIS-Plus is a flagship project aiming to consolidate our infrastructure’s capacities in the field of personalised medicine. One of the main objectives of the project is to accelerate outreach to SMEs and build long-term engagement with bioclusters. In order to be able to reach more potential industry users and further diversify EATRIS’ revenue streams, this task will pilot a collaboration programme with Biocat (comprising 1,060 companies, 580 of which biotech, medtech and pharma). Activities designed to raise the profile of the research infrastructure (RI) towards industry associations and their member companies will be evaluated, with impactful activities to be further expanded to other cluster regions. As one of the first activities, Task 6.2 - Accelerate outreach to SMEs: build long-term engagement with bioclusters aimed to further these efforts, Biocat has now performed a survey of SMEs’ needs in relation to infrastructure support and access to academic expertise and high-end facilities. The results and discussion are summarised in this Deliverable 6.1. The results of the survey will help EATRIS-Plus consortium partners refine their engagement strategy towards SMEs. EATRIS-Plus project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 871096
